Product
소개
CampBridge ELISA For Campath Biosimilar Comparison
Complete kit for the systematic 3-D conformational comparability analysis of
Campath biosimilar molecule to Alemtuzumab (Campath trade name)
Alemtuzumab is a humanized monoclonal antibody, produced by Genzyme that targets CD52,
a cell-surface receptor on lymphocytes. It is used for the treatment of chronic lymphocytic
leukemia and certain lymphomas.
This kit will allow for conformational comparison between Campath Biosimilars and
authentic Alemtuzumab.
주문정보
AB000203 CampBridge ELISA (for Campath Biosimilar Comparison) 1 Kit
관련자료